These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 30581068)

  • 1. Interleukin-13: A promising therapeutic target for autoimmune disease.
    Mao YM; Zhao CN; Leng J; Leng RX; Ye DQ; Zheng SG; Pan HF
    Cytokine Growth Factor Rev; 2019 Feb; 45():9-23. PubMed ID: 30581068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
    Rafael-Vidal C; Pérez N; Altabás I; Garcia S; Pego-Reigosa JM
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of interleukin-22 in autoimmune diseases.
    Pan HF; Li XP; Zheng SG; Ye DQ
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):51-7. PubMed ID: 22906768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular targeting in autoimmunity.
    Rogers JL; Serafin DS; Timoshchenko RG; Tarrant TK
    Curr Allergy Asthma Rep; 2012 Dec; 12(6):495-510. PubMed ID: 23054625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulatory T cells and systemic autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, primary Sjögren's syndrome].
    Bernard F; Romano A; Granel B
    Rev Med Interne; 2010 Feb; 31(2):116-27. PubMed ID: 19962219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospects of the use of cyclosporin A in rheumatic diseases].
    Nasonov EL; Shtutman VZ; Nasonova VA
    Klin Med (Mosk); 1994; 72(5):12-9. PubMed ID: 7853807
    [No Abstract]   [Full Text] [Related]  

  • 8. Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile.
    Spadaro A; Rinaldi T; Riccieri V; Taccari E; Valesini G
    Clin Exp Rheumatol; 2002; 20(2):213-6. PubMed ID: 12051401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell depletion and repopulation in autoimmune diseases.
    Pers JO; Daridon C; Bendaoud B; Devauchelle V; Berthou C; Saraux A; Youinou P
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):50-5. PubMed ID: 18270858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological therapy of arthritis and systemic autoimmune diseases].
    Tamási L; Szekanecz Z
    Orv Hetil; 2007 Apr; 148 Suppl 1():63-70. PubMed ID: 17430797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune connective tissue disease, chronic polyarthritides and B cell expansion: risks and perspectives with immunosuppressive drugs.
    Ferraccioli GF; De Vita S; Casatta L; Damato R; Pegoraro I; Bartoli E
    Clin Exp Rheumatol; 1996; 14 Suppl 14():S71-80. PubMed ID: 8722204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.
    Szabó K; Papp G; Szántó A; Tarr T; Zeher M
    Clin Exp Immunol; 2016 Jan; 183(1):76-89. PubMed ID: 26358223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune diseases in China.
    Li R; Sun X; Liu X; Yang Y; Li Z
    Adv Immunol; 2019; 144():173-216. PubMed ID: 31699217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity.
    Llorente L; Richaud-Patin Y; Fior R; Alcocer-Varela J; Wijdenes J; Fourrier BM; Galanaud P; Emilie D
    Arthritis Rheum; 1994 Nov; 37(11):1647-55. PubMed ID: 7980676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting T-helper 9 cells and interleukin-9 in autoimmune diseases.
    Pan HF; Leng RX; Li XP; Zheng SG; Ye DQ
    Cytokine Growth Factor Rev; 2013 Dec; 24(6):515-22. PubMed ID: 25215394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
    Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
    Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-9 and T helper type 9 cells in rheumatic diseases.
    Ciccia F; Guggino G; Ferrante A; Cipriani P; Giacomelli R; Triolo G
    Clin Exp Immunol; 2016 Aug; 185(2):125-32. PubMed ID: 27159882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases.
    Simon Q; Grasseau A; Boudigou M; Le Pottier L; Bettachioli E; Cornec D; Rouvière B; Jamin C; Le Lann L; ; ; Borghi MO; Aguilar-Quesada R; Renaudineau Y; Alarcón-Riquelme ME; Pers JO; Hillion S
    Arthritis Rheumatol; 2021 Aug; 73(8):1550-1561. PubMed ID: 33605069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases.
    Mirzaei R; Zamani F; Hajibaba M; Rasouli-Saravani A; Noroozbeygi M; Gorgani M; Hosseini-Fard SR; Jalalifar S; Ajdarkosh H; Abedi SH; Keyvani H; Karampoor S
    J Neuroimmunol; 2021 Sep; 358():577640. PubMed ID: 34224949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The autoimmunity-oral microbiome connection.
    Nikitakis NG; Papaioannou W; Sakkas LI; Kousvelari E
    Oral Dis; 2017 Oct; 23(7):828-839. PubMed ID: 27717092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.